(Q48018178)

7 February 2018

title

Evaluation of peripheral matrix metalloproteinase-1 in Parkinson's disease: a case-control study (English)

1 reference

7 February 2018

1 reference

Vineeta Gupta

1

1 reference

7 February 2018

Manish Kumar Singh

2

1 reference

7 February 2018

Ravindra Kumar Garg

3

1 reference

7 February 2018

Kamlesh Kumar Pant

4

1 reference

7 February 2018

Sanjay Khattri

5

1 reference

7 February 2018

publication date

6 August 2013

1 reference

7 February 2018

International Journal of Neuroscience

published in

1 reference

7 February 2018

volume

124

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

88-92

1 reference

7 February 2018

Structure and function of matrix metalloproteinases and TIMPs

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

Plasma TGF-β1, MMP-1 and MMP-3 Levels in Chronic Pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

MMP-1 polymorphism and its relationship to pathological processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

Matrix metalloproteinase-1 activates a pertussis toxin-sensitive signaling pathway that stimulates the release of matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

Exacerbation of dopaminergic terminal damage in a mouse model of Parkinson's disease by the G-protein-coupled receptor protease-activated receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.824438

10.3109/00207454.2013.824438

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018